|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aldrin | CAS 309-00-2 | ||
| C12H8Cl6 | RTECS IO2100000 | ||
|
Synonyms & Trade Names 1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-endo-1,4-exo-5,8-dimethanonaphthalene; HHDN; Octalene |
DOT ID & Guide 2761 151 |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.25 mg/m3 [skin] See Appendix A | ||
| OSHA PEL: TWA 0.25 mg/m3 [skin] | |||
| IDLH Ca [25 mg/m3] | Conversion | ||
|
Physical Description Colorless to dark-brown crystalline solid with a mild chemical odor. [Note: Formerly used as an insecticide.] |
|||
|
MW: 364.9 |
BP: Decomposes |
MLT: 219°F |
Sol: 0.003% |
|
VP: 0.00008 mmHg |
IP: ? |
|
Sp.Gr: 1.60 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid, but may be dissolved in flammable liquids. | |||
|
Incompatibilities & Reactivities Concentrated mineral acids, active metals, acid catalysts, acid oxidizing agents, phenol |
|||
|
Measurement Methods NIOSH 5502 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Headache, dizziness; nausea, vomiting, malaise (vague feeling of discomfort); myoclonic jerks of limbs; clonic, tonic convulsions; coma; hematuria (blood in the urine), azotemia; [potential occupational carcinogen] | |
|
Target Organs
central nervous system, liver, kidneys, skin Cancer Site [in animals: tumors of the lungs, liver, thyroid & adrenal glands] |
|
| See also: INTRODUCTION |